US Stock MarketDetailed Quotes

KPRX Kiora Pharmaceuticals

Watchlist
  • 3.5700
  • +0.1217+3.53%
Close Nov 27 16:00 ET
  • 3.7000
  • +0.1300+3.64%
Post 20:01 ET
10.71MMarket Cap3.40P/E (TTM)

Kiora Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
136.49%920.06K
-169.58%-3.73M
543.87%13.62M
8.35%-9.56M
-21.25%-2.58M
15.05%-2.52M
44.58%-1.38M
-8.37%-3.07M
2.32%-10.43M
27.08%-2.13M
Net income from continuing operations
40.77%-3.41M
15.00%-2.22M
819.99%13.45M
7.88%-12.51M
9.20%-2.27M
-12.57%-5.76M
-8.87%-2.61M
47.59%-1.87M
1.36%-13.58M
59.59%-2.5M
Operating gains losses
---1.36K
----
----
-101.79%-25.5K
----
----
----
----
610.76%1.42M
--0
Depreciation and amortization
-81.47%2.1K
-71.84%6.33K
-51.69%4.87K
24.49%51.8K
-22.85%7.94K
10.11%11.31K
118.63%22.48K
-6.45%10.08K
-8.14%41.61K
-6.81%10.29K
Deferred tax
----
----
----
179.92%90.32K
----
----
----
----
41.32%-113.01K
----
Other non cash items
-173.23%-1.13M
-16.20%149.03K
-100.35%-851
196.73%2M
190.93%39.01K
324.48%1.54M
157.43%177.84K
-15.19%241.7K
308.54%675.02K
-49.30%-42.9K
Change In working capital
782.72%3.3M
-301.66%-1.73M
99.51%-7.81K
-372.54%-1.82M
-229.13%-606.84K
-317.46%-483.12K
444.44%856.78K
-805.65%-1.59M
164.54%668.51K
160.39%469.95K
-Change in receivables
572.83%2.72M
-284.83%-1.64M
96.74%-10.82K
37.20%-548.11K
-275.57%-529.11K
48.00%-575.17K
2,671.61%888.47K
-891.99%-332.29K
-97.81%-872.74K
384.05%301.37K
-Change in prepaid assets
-635.24%-130.12K
-159.94%-132.7K
108.62%12.65K
-99.68%885
-46.51%-97.97K
-97.94%24.31K
143.01%221.38K
54.66%-146.84K
275.32%275.16K
74.76%-66.87K
-Change in payables and accrued expense
721.88%718.22K
123.43%51.35K
100.05%584
-191.06%-1.27M
-124.52%-58.68K
-48.53%87.39K
-164.71%-219.13K
-267.17%-1.08M
616.04%1.39M
166.49%239.35K
-Change in other current assets
1,119.11%2.74K
2,438.73%7.21K
158.60%1.11K
66.25%-7.58K
65.99%-8.52K
-96.25%225
-96.19%284
103.96%430
-259.20%-22.47K
-2,050.27%-25.06K
-Change in other current liabilities
38.91%-12.14K
66.25%-11.55K
65.40%-11.34K
100.56%584
313.36%87.45K
29.31%-19.86K
24.92%-34.22K
35.86%-32.78K
43.05%-103.63K
143.65%21.16K
Cash from discontinued investing activities
Operating cash flow
136.49%920.06K
-169.58%-3.73M
543.87%13.62M
8.35%-9.56M
-21.25%-2.58M
15.05%-2.52M
44.58%-1.38M
-8.37%-3.07M
2.32%-10.43M
27.08%-2.13M
Investing cash flow
Cash flow from continuing investing activities
-1.92M
0
0
0
104.06%6.38K
0
Net PPE purchase and sale
--0
----
----
--0
--0
--0
----
----
109.98%6.38K
--0
Net investment purchase and sale
---1.92M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---1.92M
----
----
--0
--0
--0
----
----
104.06%6.38K
--0
Financing cash flow
Cash flow from continuing financing activities
0
-95.78%250.52K
2,871.23%15.25M
-30.80%5.97M
-115.00%-486.42K
0
5.94M
513.18K
-50.97%8.62M
1,627.78%3.24M
Net common stock issuance
--0
-82.38%1.19M
6,332.43%13.81M
14.77%6.15M
-56.21%-813.32K
--0
--6.75M
--214.68K
-69.78%5.36M
---520.65K
Proceeds from stock option exercised by employees
--0
--250.52K
382.02%1.44M
-90.58%307.08K
-99.74%8.58K
--0
--0
--298.5K
6,417.53%3.26M
--3.26M
Net other financing activities
--0
----
----
---495K
--318.32K
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-95.78%250.52K
2,871.23%15.25M
-30.80%5.97M
-115.00%-486.42K
--0
--5.94M
--513.18K
-50.97%8.62M
1,627.78%3.24M
Net cash flow
Beginning cash position
-17.30%6.58M
811.90%31.28M
-59.11%2.46M
-23.87%6.01M
11.42%5.4M
221.16%7.96M
-32.90%3.43M
-23.87%6.01M
541.90%7.9M
-56.50%4.85M
Current changes in cash
60.32%-1M
-642.51%-24.71M
1,229.41%28.87M
-99.40%-3.59M
-375.33%-3.07M
-204.61%-2.52M
282.25%4.55M
9.54%-2.56M
-126.68%-1.8M
134.55%1.11M
Effect of exchange rate changes
306.47%62.3K
124.19%6.98K
-87.97%-51.02K
142.36%36.02K
149.55%122.18K
17.26%-30.17K
78.82%-28.85K
-170.19%-27.15K
-4.34%-85.04K
280.45%48.96K
End cash Position
4.39%5.64M
-17.30%6.58M
811.90%31.28M
-59.11%2.46M
-59.11%2.46M
11.42%5.4M
221.16%7.96M
-32.90%3.43M
-23.87%6.01M
-23.87%6.01M
Free cash flow
136.49%920.06K
-173.28%-3.78M
543.87%13.62M
8.35%-9.56M
-21.25%-2.58M
15.05%-2.52M
44.58%-1.38M
-8.37%-3.07M
2.90%-10.43M
27.08%-2.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 136.49%920.06K-169.58%-3.73M543.87%13.62M8.35%-9.56M-21.25%-2.58M15.05%-2.52M44.58%-1.38M-8.37%-3.07M2.32%-10.43M27.08%-2.13M
Net income from continuing operations 40.77%-3.41M15.00%-2.22M819.99%13.45M7.88%-12.51M9.20%-2.27M-12.57%-5.76M-8.87%-2.61M47.59%-1.87M1.36%-13.58M59.59%-2.5M
Operating gains losses ---1.36K---------101.79%-25.5K----------------610.76%1.42M--0
Depreciation and amortization -81.47%2.1K-71.84%6.33K-51.69%4.87K24.49%51.8K-22.85%7.94K10.11%11.31K118.63%22.48K-6.45%10.08K-8.14%41.61K-6.81%10.29K
Deferred tax ------------179.92%90.32K----------------41.32%-113.01K----
Other non cash items -173.23%-1.13M-16.20%149.03K-100.35%-851196.73%2M190.93%39.01K324.48%1.54M157.43%177.84K-15.19%241.7K308.54%675.02K-49.30%-42.9K
Change In working capital 782.72%3.3M-301.66%-1.73M99.51%-7.81K-372.54%-1.82M-229.13%-606.84K-317.46%-483.12K444.44%856.78K-805.65%-1.59M164.54%668.51K160.39%469.95K
-Change in receivables 572.83%2.72M-284.83%-1.64M96.74%-10.82K37.20%-548.11K-275.57%-529.11K48.00%-575.17K2,671.61%888.47K-891.99%-332.29K-97.81%-872.74K384.05%301.37K
-Change in prepaid assets -635.24%-130.12K-159.94%-132.7K108.62%12.65K-99.68%885-46.51%-97.97K-97.94%24.31K143.01%221.38K54.66%-146.84K275.32%275.16K74.76%-66.87K
-Change in payables and accrued expense 721.88%718.22K123.43%51.35K100.05%584-191.06%-1.27M-124.52%-58.68K-48.53%87.39K-164.71%-219.13K-267.17%-1.08M616.04%1.39M166.49%239.35K
-Change in other current assets 1,119.11%2.74K2,438.73%7.21K158.60%1.11K66.25%-7.58K65.99%-8.52K-96.25%225-96.19%284103.96%430-259.20%-22.47K-2,050.27%-25.06K
-Change in other current liabilities 38.91%-12.14K66.25%-11.55K65.40%-11.34K100.56%584313.36%87.45K29.31%-19.86K24.92%-34.22K35.86%-32.78K43.05%-103.63K143.65%21.16K
Cash from discontinued investing activities
Operating cash flow 136.49%920.06K-169.58%-3.73M543.87%13.62M8.35%-9.56M-21.25%-2.58M15.05%-2.52M44.58%-1.38M-8.37%-3.07M2.32%-10.43M27.08%-2.13M
Investing cash flow
Cash flow from continuing investing activities -1.92M000104.06%6.38K0
Net PPE purchase and sale --0----------0--0--0--------109.98%6.38K--0
Net investment purchase and sale ---1.92M------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---1.92M----------0--0--0--------104.06%6.38K--0
Financing cash flow
Cash flow from continuing financing activities 0-95.78%250.52K2,871.23%15.25M-30.80%5.97M-115.00%-486.42K05.94M513.18K-50.97%8.62M1,627.78%3.24M
Net common stock issuance --0-82.38%1.19M6,332.43%13.81M14.77%6.15M-56.21%-813.32K--0--6.75M--214.68K-69.78%5.36M---520.65K
Proceeds from stock option exercised by employees --0--250.52K382.02%1.44M-90.58%307.08K-99.74%8.58K--0--0--298.5K6,417.53%3.26M--3.26M
Net other financing activities --0-----------495K--318.32K--0----------------
Cash from discontinued financing activities
Financing cash flow --0-95.78%250.52K2,871.23%15.25M-30.80%5.97M-115.00%-486.42K--0--5.94M--513.18K-50.97%8.62M1,627.78%3.24M
Net cash flow
Beginning cash position -17.30%6.58M811.90%31.28M-59.11%2.46M-23.87%6.01M11.42%5.4M221.16%7.96M-32.90%3.43M-23.87%6.01M541.90%7.9M-56.50%4.85M
Current changes in cash 60.32%-1M-642.51%-24.71M1,229.41%28.87M-99.40%-3.59M-375.33%-3.07M-204.61%-2.52M282.25%4.55M9.54%-2.56M-126.68%-1.8M134.55%1.11M
Effect of exchange rate changes 306.47%62.3K124.19%6.98K-87.97%-51.02K142.36%36.02K149.55%122.18K17.26%-30.17K78.82%-28.85K-170.19%-27.15K-4.34%-85.04K280.45%48.96K
End cash Position 4.39%5.64M-17.30%6.58M811.90%31.28M-59.11%2.46M-59.11%2.46M11.42%5.4M221.16%7.96M-32.90%3.43M-23.87%6.01M-23.87%6.01M
Free cash flow 136.49%920.06K-173.28%-3.78M543.87%13.62M8.35%-9.56M-21.25%-2.58M15.05%-2.52M44.58%-1.38M-8.37%-3.07M2.90%-10.43M27.08%-2.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data